AstraZeneca PLC <AZN.OQ> expected to post earnings of $1.03 a share - Earnings Preview
AstraZeneca PLC AZN.OQ, AZN.O is expected to show a rise in quarterly revenue when it reports results on November 12 for the period ending September 30 2024
The Cambridge United Kingdom-based company is expected to report a 13.9% increase in revenue to $13.088 billion from $11.49 billion a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for AstraZeneca PLC is for earnings of $1.03 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for AstraZeneca PLC is 91.70, above its last closing price of $64.69.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2024 | 1.17 | 1.00 | 0.99 | Missed | -1 |
Mar. 31 2024 | 1.20 | 1.22 | 1.03 | Missed | -15.8 |
Dec. 31 2023 | 0.76 | 0.79 | 0.73 | Missed | -7.8 |
Sep. 30 2023 | 0.84 | 0.85 | 0.87 | Beat | 3 |
Jan. 1 0001 | 1.01 | 0.95 | 1.08 | Beat | 13.7 |
Mar. 31 2023 | 1.13 | 1.07 | 0.96 | Missed | -10.3 |
Dec. 31 2022 | 0.67 | 0.67 | 0.69 | Beat | 3 |
Jan. 1 0001 | 0.72 | 0.72 | 0.84 | Beat | 16.7 |
This summary was machine generated November 8 at 16:03 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
</body></html>
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
